Schaefer F, Wolf S, Klaus G, Langenbeck D, Mehls O
Pediatric Nephrology Division, University Children's Hospital, Heidelberg, Germany.
Adv Perit Dial. 1994;10:310-4.
Being more suitable to children's lifestyle habits, continuous cycling peritoneal dialysis (CCPD) is becoming the treatment modality of first choice in the pediatric CPD population. In order to establish whether these regimens, prescribed on an empirical basis, provide an equally effective dialysis as does standard continuous ambulatory peritoneal dialysis (CAPD), we performed a cross-sectional analysis of dialysate and residual renal small molecule clearances in 85 children aged 3 months to 20 years, who were treated in 16 pediatric dialysis centers. Forty-three children were on CAPD and 42 were on CCPD. The two patient groups did not differ in age, body size, duration of dialysis, underlying disease distribution, or residual renal function. The CAPD patients achieved an average daily drain volume of 159 +/- 40 mL/kg body weight, as compared to 208 +/- 95 mL/kg in the CCPD group (p < 0.005). Average serum creatinine and BUN values were similar in both groups. While the (total) creatinine clearance did not differ, the KT/V urea was significantly higher in the patients treated with CCPD (0.35 +/- 0.12 vs 0.28 +/- 0.13, p < 0.05). The estimated protein catabolic rate (PCR) was significantly higher in the CCPD group (1.39 +/- 0.6 g/kg d) than in the CAPD patients (1.08 +/- 0.48 g/kg d, p < 0.05). Three-day dietary histories, available in 20 patients, showed a similar difference in dietary protein intake between CCPD and CAPD patients. We conclude that CCPD treatment regimens, at the dose currently prescribed in Mid-European pediatric dialysis centers, provide a higher clearance of urea and, possibly, other small molecules.(ABSTRACT TRUNCATED AT 250 WORDS)
持续循环腹膜透析(CCPD)更适合儿童的生活方式习惯,正成为儿科腹膜透析人群的首选治疗方式。为了确定这些基于经验开出的治疗方案是否能提供与标准持续性非卧床腹膜透析(CAPD)同样有效的透析效果,我们对16个儿科透析中心治疗的85名3个月至20岁儿童的透析液和残余肾小分子清除率进行了横断面分析。43名儿童接受CAPD治疗,42名接受CCPD治疗。两组患者在年龄、体型、透析时间长短、基础疾病分布或残余肾功能方面没有差异。CAPD患者的平均每日引流量为159±40 mL/千克体重,而CCPD组为208±95 mL/千克体重(p<0.005)。两组的平均血清肌酐和尿素氮值相似。虽然(总)肌酐清除率没有差异,但CCPD治疗的患者的尿素清除率(KT/V)显著更高(0.35±0.12对0.28±0.13,p<0.05)。CCPD组的估计蛋白质分解代谢率(PCR)显著高于CAPD患者(1.39±0.6克/千克·天对1.08±0.48克/千克·天,p<0.05)。20名患者提供的三日饮食史显示,CCPD和CAPD患者在饮食蛋白质摄入量上也有类似差异。我们得出结论,在欧洲中部儿科透析中心目前规定的剂量下,CCPD治疗方案能提供更高的尿素清除率,可能还有其他小分子的清除率。(摘要截选至250词)